L. Pampa-Espinoza

Molecular characterization of carbapenemases in Peru during 2019.

M. Mayta-Barrios, Juan José Ramirez-Illescas, L. Pampa-Espinoza, 2021, Revista peruana de medicina experimental y salud publica.

Reinfections are more frequent than currently considered in countries with high incidence of COVID-19 cases due to stringent definitions

L. Solari, J. Silva-Valencia, C. Padilla-Rojas, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru

L. Solari, O. Cáceres, M. Galarza, 2022, Open forum infectious diseases.

Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP) is an effective alternative for SARS-CoV-2 molecular detection in middle-income countries

C. Cabezas, R. Gavilán, O. Escalante-Maldonado, 2020, medRxiv.

Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru

L. Solari, J. Silva-Valencia, R. Araujo-Castillo, 2022, medRxiv.

Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2.

C. Cabezas, R. Gavilán, O. Escalante-Maldonado, 2021, Revista peruana de medicina experimental y salud publica.

I g G antibody response by ELISA using Wuhan and Lambda variant antigens in BBIBP-CORV vaccinated health care workers

L. Solari, L. Pampa-Espinoza, M. Huaringa-Núñez, 2022 .

IgG antibody response by ELISA using Wuhan and Lambda variant antigens in BBIBP-CORV vaccinated health care workers.

L. Solari, Lely Solari, L. Pampa-Espinoza, 2022, Revista peruana de medicina experimental y salud publica.